🇺🇸 FDA
Patent

US 10456346

Cosmetic formulations for topical applications containing erythropoietin-derived molecules

granted A61KA61K8/64

Quick answer

US patent 10456346 (Cosmetic formulations for topical applications containing erythropoietin-derived molecules) held by ASC REGENITY LIMITED expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ASC REGENITY LIMITED
Grant date
Tue Oct 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K8/64